Drug Approval And SalesTIVDAK receives full FDA approval, showing superior efficacy over chemotherapy, which could significantly boost Genmab's market presence and stock value.
Financial PerformanceGMAB reported positive financial results, exceeding consensus revenue expectations, reflecting the company's financial strength and strong market performance.
Product LaunchThe strong launch and revenue generation of partnered product Epkinly in the US and Japan signals promising growth and market acceptance.